Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

XPA antibody (full length)

This Mouse Monoclonal antibody specifically detects XPA in WB, ELISA and Inhibition. It exhibits reactivity toward Human and has been mentioned in 2+ publications.
Catalog No. ABIN3200998

Quick Overview for XPA antibody (full length) (ABIN3200998)

Target

See all XPA Antibodies
XPA (Xeroderma Pigmentosum, Complementation Group A (XPA))

Reactivity

  • 48
  • 16
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 44
  • 4
Mouse

Clonality

  • 46
  • 2
Monoclonal

Conjugate

  • 31
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This XPA antibody is un-conjugated

Application

  • 38
  • 20
  • 12
  • 8
  • 7
  • 6
  • 5
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)

Clone

5F12
  • Binding Specificity

    • 8
    • 8
    • 8
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    full length

    Cross-Reactivity

    Mouse (Murine)

    Cross-Reactivity (Details)

    Expected to react also with mouse XPA from the sequence homology.

    Purification

    Purified

    Sterility

    Sterile filtered

    Immunogen

    Recombinant full-length human XPA protein

    Isotype

    IgG2b
  • Application Notes

    1. Western blotting: 0. 1~1 g/mL
    2. ELISA
    3. Inhibition of in vitro excision repair reaction
    4. Inhibition of XPA interaction with ERCC1 and TFIIH
    Other applications have not been tested.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS pH 7.2, 50 % glycerol

    Preservative

    Azide free

    Storage

    -20 °C/-80 °C

    Storage Comment

    -20 C (For long term storage: -70 C)
  • Saijo, Matsuda, Kuraoka, Tanaka: "Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH." in: Biochemical and biophysical research communications, Vol. 321, Issue 4, pp. 815-22, (2004) (PubMed).

    Tanaka, Miura, Satokata, Miyamoto, Yoshida, Satoh, Kondo, Yasui, Okayama, Okada: "Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain." in: Nature, Vol. 348, Issue 6296, pp. 73-6, (1990) (PubMed).

  • Target

    XPA (Xeroderma Pigmentosum, Complementation Group A (XPA))

    Alternative Name

    XPA

    Background

    XP (Xeroderma pigmentosum) is an autosomal recessive human disease characterized by hypersensitivity to sunlight and a high incidence of skin cancer on sun-exposed skin. Cells from XP patients are hypersensitive to killing by UV irradiation because of a defect in nucleotide excision repair (NER). XP is classified into seven complementation groups (A~G) and a variant form. XPA shows the most severe symptoms. Products encoded by the XP genes function in repairing UV-induced cyclobutane pyrimidine dimmer and (6-4) photoproducts as well as chemically induced variety of DNA lesions. XPA protein consists of 273 amino acids and forms a complex with many proteins such as RPA, ERCC1, TFIIH,XAB1, and XAB2, which plays a role in early step of NER. The hybridoma 5F12 was constructed by Prof. K. Tanaka's group who first cloned the XPA gene.

    UniProt

    P23025

    Pathways

    DNA Damage Repair
You are here:
Chat with us!